Biotech SPACs: A new route to going public
Manage episode 287216905 series 2838531
As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies access public markets long-term? Our investment banking team goes inside the SPAC boom to explain what companies need to know before choosing their path to going public.
31 episódios